GEZER U[au] - Search Results

Year	Number of Results
2011	1
2012	5
2013	4
2014	6
2015	7
2016	3
2017	2
2018	2
2019	2
2020	4
2021	2
2022	2

1

Blood-based biomarkers for diagnosis, prognosis and treatment of colorectal cancer.

Yörüker EE, Holdenrieder S, Gezer U. Yörüker EE, et al. Among authors: gezer u. Clin Chim Acta. 2016 Apr 1;455:26-32. doi: 10.1016/j.cca.2016.01.016. Epub 2016 Jan 18. Clin Chim Acta. 2016. PMID: 26797671 Review.

2

Impact of histone methyltransferase SUV420H2 in breast cancer.

Isin H, Özgür E, Talu CK, Trabulus DC, Karaçetin D, Gezer U. Isin H, et al. Among authors: gezer u. Biomed Rep. 2020 Oct;13(4):29. doi: 10.3892/br.2020.1336. Epub 2020 Jul 23. Biomed Rep. 2020. PMID: 32765868 Free PMC article.

3

Post-translational histone modifications in circulating nucleosomes as new biomarkers in colorectal cancer.

Gezer U, Holdenrieder S. Gezer U, et al. In Vivo. 2014 May-Jun;28(3):287-92. In Vivo. 2014. PMID: 24815828 Review.

4

The Utility of Repetitive Cell-Free DNA in Cancer Liquid Biopsies.

Gezer U, Bronkhorst AJ, Holdenrieder S. Gezer U, et al. Diagnostics (Basel). 2022 Jun 1;12(6):1363. doi: 10.3390/diagnostics12061363. Diagnostics (Basel). 2022. PMID: 35741173 Free PMC article. Review.

5

Fragmentation Analysis of Plasma DNA Reveals Its Prognostic Value in Gastric Cancer.

Yoruker EE, Ozgur E, Keskin M, Ozgur I, Gezer U. Yoruker EE, et al. Among authors: gezer u. Turk J Gastroenterol. 2021 Sep;32(9):720-726. doi: 10.5152/tjg.2021.20832. Turk J Gastroenterol. 2021. PMID: 34609300 Free PMC article.

6

Increased DNA integrity in colorectal cancer.

Leszinski G, Lehner J, Gezer U, Holdenrieder S. Leszinski G, et al. Among authors: gezer u. In Vivo. 2014 May-Jun;28(3):299-303. In Vivo. 2014. PMID: 24815830

7

Satellite 2 repeat DNA in blood plasma as a candidate biomarker for the detection of cancer.

Özgür E, Mayer Z, Keskin M, Yörüker EE, Holdenrieder S, Gezer U. Özgür E, et al. Among authors: gezer u. Clin Chim Acta. 2021 Mar;514:74-79. doi: 10.1016/j.cca.2020.12.008. Epub 2020 Dec 31. Clin Chim Acta. 2021. PMID: 33333039

8

Investigation of circulating lncRNAs in B-cell neoplasms.

Isin M, Ozgur E, Cetin G, Erten N, Aktan M, Gezer U, Dalay N. Isin M, et al. Among authors: gezer u. Clin Chim Acta. 2014 Apr 20;431:255-9. doi: 10.1016/j.cca.2014.02.010. Epub 2014 Feb 26. Clin Chim Acta. 2014. PMID: 24583225

9

Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer.

Özgür E, Ferhatoğlu F, Şen F, Saip P, Gezer U. Özgür E, et al. Among authors: gezer u. Cancer Biomark. 2020;27(1):11-17. doi: 10.3233/CBM-190085. Cancer Biomark. 2020. PMID: 31640083

10

Accumulation of GAS5 in exosomes is a marker of apoptosis induction.

Koldemir O, Özgür E, Gezer U. Koldemir O, et al. Among authors: gezer u. Biomed Rep. 2017 Mar;6(3):358-362. doi: 10.3892/br.2017.848. Epub 2017 Jan 25. Biomed Rep. 2017. PMID: 28451400 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results